MSCGro Media-locity

We can say our MSCGro^TM Media Mesenchymal stem Cell Media stacks up well vs our competition. The proof, though, is in the data and what our customers say. Here's a testimonial: ""Your MSC-Gro^TMmedia worked great. We carried out a simple pilot study where we plated an equal number of cells from a few CAF samples in both our traditional media and yours. We took a look at the cells on a daily basis, and by 3-4 days we saw a clear increase in cell numbers using your media." Obdulio Piloto, Ph.D., CSO of Conversantbio Inc.

And here is data:

Check out our MSCGro Media for yourself and if you re not delighted with the results, we will refund 100% of your purchase.

Mesechymal Stem Cell DifferentiationPathways

As a provider of Human Mesenchymal Stem Cells (hMSCs), MSCGro™ Mesenchymal Stem Cell Media and Stem Cell Markers, I receive questions related to differentiation. Specifically, researchers desire to drive these cells to specific progenitor and cell phenotypes like Osteocytes, Adipocytes and Chondroytes.

I would like to share a pathway map that gives a snapshot of these pathways:

Regenerative Biology of the Spine and Spinal Cord. Edited by: Rahul Jandial, Mike Y. Chen, Bihong T. Chen and Joseph Ciacci. ISBN: 978-1-4614-4089-5. Publication date: May 25, 2012. Series: Special Books

I will continue to post information that will enable the researchers to harness the power of Mesenchymal Stem Cells.

New Human Mesenchymal Stem Cells

Neuromics' is responding to growing demand for Stem Cell Research Reagents.

This includes the addition of human stem cells giving researchers the ability to create consistent cultures of primary cells. Our first offering was STEMEZ ^TM hNP1 Human Neural Progenitors. We have received positive feedback on these regarding ease of use and quality.

We are pleased to announce the addition of Human Mesenchymal Stem Cells.

Image: Pancreas-derived human mesenchymal stem cells labeled with a CD44 monoclonal antibody conjugated to fluorescein isothiocyanate (FITC), which detects the CD44 cell surface protein.

They are isolated from human adult pancreas and can be induced to differentiate into beta-cells, which is a significant product in the diabetes research area. MSCs to Beta Cells Protocol.

This is extremely important due to the low yield of islets from patients/donors. These cells could be a functional equivalent to normal beta-cells and could restore proper endocrine function to the pancreas.

In addition, protocols are available to differentiate these cells into osteocytes, adipocytes, chondrocytes and hepatocytes.

We will keep you posted on customer results with this important new product.